Managing occluded stents in biliary obstruction using radiofrequency ablation combined with 125I-strand brachytherapy
PDF
Cite
Share
Request
Interventional Radiology - Original Article
P: 79-84
January 2021

Managing occluded stents in biliary obstruction using radiofrequency ablation combined with 125I-strand brachytherapy

Diagn Interv Radiol 2021;27(1):79-84
1. Department of interventional radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
No information available.
No information available
Received Date: 19.03.2020
Accepted Date: 06.05.2020
PDF
Cite
Share
Request

ABSTRACT

PURPOSE

We aimed to assess the effectiveness of percutaneous radiofrequency ablation (PRFA) combined with iodine-125 (125I) seed strand brachytherapy (125I-BT) for treatment of occluded biliary stents.

METHODS

From November 2015 to September 2017, 13 consecutive patients with occluded biliary metal stents, implanted for malignant obstruction, underwent PRFA combined with 125I-BT to reopen the bile duct. Data included clinical and technical success, stent patency, complications, and overall survival.

RESULTS

The clinical and technical success rates were both 100%. One month after treatment, the total serum bilirubin level had decreased significantly (P < 0.001). Early complications of cholangitis or hemobilia were experienced by one patient each. Three patients (23.1%) had late complications, including two cases of cholangitis and one case of cholecystitis. During the mean follow-up of 233±82.9 days (range, 88–365 days), the stent patency time was 239±26.5 days (95% CI, 187–291 days), and the 6-month stent patency rate was 68.4%. Five patents died; the mean survival time was 298±30.1 days (95% CI, 239–358 days). The 6-month survival rate was 83%.

CONCLUSION

PRFA therapy combined with 125I-BT is feasible and safe for patients with occluded metal stents placed for malignant biliary obstruction. Nevertheless, randomized controlled trails are needed to confirm the effectiveness of this new approach.